De novo expression of the α5β1-fibronectin receptor in HT29 colon- cancer cells reduces activity of c-src. Increase of c-src activity by attachment on fibronectin

International Journal of Cancer

Volumn 76, Issue 1, 1998, Pages 91-98

  Schmidt, Roland ^a   Streit, Michael ^b   Kaiser, Rolf ^b   Herzberg, Frank ^b   Schirner, Michael ^c   Schramm, Kira ^b   Kaufmann, Christine ^b   Henneken, Maren ^a   Schäfer Korting, Monika ^a   Thiel, Eckhard ^b   Kreuser, Ernst Dietrich ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTEGRIN; PAXILLIN; SCLEROPROTEIN;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA CELL; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

CELL ADHESION; CELL ADHESION MOLECULES; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HT29 CELLS; HUMANS; PAXILLIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTORS, FIBRONECTIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0031981769     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980330)76:1<91::AID-IJC15>3.0.CO;2-J     Document Type: Article

References (23)

1. BOS, J.L., FEARON, E.R., HAMILTON, S.R., VERLAAN-DE VRIES, M., VAN BOOM J.H., VAN DER EB, A.J. and VOGELSTEIN, B., Prevalence of ras-gene mutations in human colorectal cancers. Nature (Lond.), 327, 293-297 (1987).
2. c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets. Mol. cell. Biol., 13, 1863-1871 (1993).
3. CLARK, E.A. and BRUGGE, J.S., Integrins and signal-transduction pathways: the road taken. Science, 268, 233-239 (1995).
4. FAK. Mol. cell. Biol., 332, 272-275 (1994).
5. FRIEDMANN, E., VERDERAME, M., LIPKIN, M. and POLLACK, R., Altered actin cytoskeletal patterns in two pre-malignant stages in human colon-carcinoma development. Cancer Res., 45, 3236-3242 (1985).
6. c-src activity in human colon-tumor cell lines. Oncogene, 6, 1983-1989 (1991).
7. GIANCOTTI, F.G. and MAINIERO, F., Integrin-mediated adhesion and signaling in tumorigenesis. Biochim. biophys. Acta, 1198, 47-64 (1994).
8. GIANCOTTI, F.G. and RUOSLAHTI, E., Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese-hamster ovary cells. Cell, 60, 849-859 (1990).
9. fyn (a src-like protein tyrosine kinase) in normal and polyoma virus transformed cells. EMBO, 7, 3837-3844 (1988).
10. GLENNEY, J.R. and ZOKAS, L., Novel tyrosine kinase substrates from Rous-sarcoma-virus-transformed cells are present in the membrane skeleton. J. Cell Biol., 108, 2401-2408 (1989).
11. KOPELOVICH, L., LIPKIN, M., BLATTNER, W.A., FRAUMENI, J.F., LYNCH, H.T. and POLLACK, R.E., Organisation of actin-containing cables in cultured fibroblasts from individuals at high risk of colon cancer. Int. J. Cancer, 26, 301-307 (1980).
12. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
13. SAKAI, R., NAGURA, K., ISHINO, M., TOBIOKA, H., KOTANI, K. and SASAKI, A., A novel signaling molecule forms a stable complex in vivo with v-crk and v-src in a tyrosine-phosphorylation-dependent manner, EMBO J., 13, 3748-3756 (1994).
14. FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. nat. Acad. Sci. (Wash.), 89, 5192-5196 (1992).
15. SCHREINER, C., FISHER, M., HUSSEIN, S. and JULIANO, R.L., Increased tumorigenicity of fibronectin-receptor-deficient Chinese-hamster ovary-cell variants. Cancer Res., 51, 1738-1740 (1991).
16. STALLMACH, A., VON LAMPE, B., MATTHES, H., BORNHOFT, G. and RIECKEN, E.O., Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign-to-malign tumor transformation. Gut, 33, 342-346 (1992).
17. SYMINGTON, B.E., Fibronectin receptor overexpression and loss of transformed phenotype in a stable variant of the K562 cell line. Cell. Regul., 1, 637-648 (1990).
18. TAYLOR, S.J. and SHALLOWAY, D., The cell cycle and c-Src. Curr. Opin. Genet. Dev., 3, 26-34 (1993).
19. VARNER, J.A., EMERSON, D.A. and JULIANO, R.L., Integrin α5β1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol. Biol. Cell, 6, 725-740 (1995).
20. WEBER, T.K., STEELE, G. and SUMMERHAYES, C., Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines. J. clin. Invest., 90, 815-821 (1992).
21. WEINEL, R.J., ROSENDAHL, A., NEUMANN, K., CHALOUPKA, B., ERB, D., ROTHMUND, J. and SANTOSO, S., Expression and function of VLA-alpha-2, -alpha-3, -alpha-5 and -alpha-6-integrin receptors in pancreatic carcinoma. Int. J. Cancer, 52, 827-833 (1992).
22. H2 protooncogenes in cancers are frequent and show clinical correlation. Science, 231, 261-265 (1986).
23. ZUTTER, M.M., MAZOUJIAN, G. and SANTORO, S.A., Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Amer. J. Path., 137, 863-870 (1990).